『徳島大学 教育・研究者情報データベース (EDB)』---[学外] /
ID: Pass:
  (見出し語句検索:)

登録情報

抽出条件

OWN=閲覧 軒原 浩 ([徳島大学.大学院医歯薬学研究部.医学域.医科学部門.内科系.呼吸器・膠原病内科学])

登録情報の数

有効な情報: 15件 + 無効な情報: 6件 = 全ての情報: 21件

全ての有効な情報 (15件)
  (見出し語句検索:)

条件追加

[種別](著作の種別)による分類 :
[言語](著作の言語)による分類 :
[カテゴリ](著作のカテゴリ)による分類 :
[共著種別](共著の種別)による分類 :
[学究種別](著作の学究種別)による分類 :
[組織](著作の帰属する組織)による分類 :
閲覧 (未定義) …(15)
[年月日](発行年月日)による分類
○ 年による分類 :
○ 年度による分類 :

抽出結果のリスト

排列順: 項目表示:
閲覧 (種別) : Yutaka Fujiwara, Naoya Yamazaki, Yoshio Kiyohara, Shusuke Yoshikawa, Noboru Yamamoto, Arata Tsutsumida, Hiroshi Nokihara, Kenjiro Namikawa, Akihira Mukaiyama, Fanghong Zhang and Tomohide Tamura : Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF mutation-positive solid tumors: a phase 1 study., Investigational New Drugs, Vol.36, No.2, 259-268, (発行所), (都市), Sep. 2017. ...
閲覧 (種別) : Sayaka Ohara, Shintaro Kanda, Hitomi Okuma, Yasushi Goto, Hidehito Horinouchi, Yutaka Fujiwara, Hiroshi Nokihara, Yoshinori Ito, Noboru Yamamoto, Kazuhiro Usui, Sakae Homma and Yuichiro Ohe : Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions., Japanese Journal of Clinical Oncology, Vol.48, No.1, 82-88, (発行所), (都市), Jan. 2018. ...
閲覧 (種別) : Hidehito Horinouchi, Kaoru Kubota, Akihiko Miyanaga, Shinji Nakamichi, Masahiro Seike, Akihiko Gemma, Yuki Yamane, Futoshi Kurimoto, Hiroshi Sakai, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Tomohide Tamura and Yuichiro Ohe : Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trial., ESMO Open, Vol.3, No.1, e000288, (発行所), (都市), Jan. 2018. ...
閲覧 (種別) : Toyoaki Hida, Reiko Kaji, Miyako Satouchi, Norihiko Ikeda, Atsushi Horiike, Hiroshi Nokihara, Takashi Seto, Tomohisa Kawakami, Shintaro Nakagawa and Toshio Kubo : Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study., Clinical Lung Cancer, Vol.19, No.4, e405-e415, (発行所), (都市), Feb. 2018. ...
閲覧 (種別) : Yoshitaka Seki, Yutaka Fujiwara, Takashi Kohno, Kazushi Yoshida, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Kazuyoshi Kuwano and Yuichiro Ohe : Circulating cell-free plasma tumour DNA shows a higher incidence of mutations in patients with extrathoracic disease progression., ESMO Open, Vol.3, No.2, e000292, (発行所), (都市), Feb. 2018. ...
閲覧 (種別) : Jun Sato, Hidehito Horinouchi, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto and Yuichiro Ohe : Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisited., Journal of Thoracic Disease, Vol.10, No.3, 1696-1702, (発行所), (都市), March 2018. ...
閲覧 (種別) : Midori Tanaka, Hidehito Horinouchi, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto and Yuichiro Ohe : Reduction in nephrotoxicities using short hydration for chemotherapy containing cisplatin: a consecutive analysis of 467 patients with thoracic malignancies., ESMO Open, Vol.3, No.4, e000342, (発行所), (都市), May 2018. ...
閲覧 (種別) : Haruyasu Murakami, Hiroshi Nokihara, Hidetoshi Hayashi, Takashi Seto, Keunchil Park, Koichi Azuma, Chun-Ming Tsai, James Chih-Hsin Yang, Makoto Nishio, Sang-We Kim, Katsuyuki Kiura, Akira Inoue, Koji Takeda, Jin-Hyoung Kang, Tomoki Nakagawa, Kentaro Takeda, Rio Akazawa, Yuichiro Kaneko, Masashi Shimazaki, Satoshi Morita, Masahiro Fukuoka and Kazuhiko Nakagawa : Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations., Cancer Science, Vol.109, No.9, 2852-2862, (発行所), (都市), Aug. 2018. ...
閲覧 (種別) : Kazuma Kishi, Hiroshi Sakai, Takashi Seto, Toshiyuki Kozuki, Makoto Nishio, Fumio Imamura, Hiroshi Nokihara, Miyako Satouchi, Shintaro Nakagawa, Takashi Tahata and Kazuhiko Nakagawa : First-line onartuzumab plus erlotinib treatment for patients with MET-positive and EGFR mutation-positive non-small-cell lung cancer., Cancer Treatment and Research Communications, Vol.18, (号), 100113, (発行所), (都市), Oct. 2018. ...
閲覧 (種別) : Hiroshi Nokihara, Makoto Nishio, Noboru Yamamoto, Yutaka Fujiwara, Hidehito Horinouchi, Shintaro Kanda, Atsushi Horiike, Fumiyoshi Ohyanagi, Noriko Yanagitani, Linh Nguyen, Yifah Yaron, Anne Borgman and Tomohide Tamura : Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer., Clinical Lung Cancer, Vol.20, No.3, e317-e328, (発行所), (都市), Dec. 2018. ...
閲覧 (種別) : Shunichi Sugawara, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Hiroshi Nokihara, Yuichiro Ohe, Makoto Nishio, Toshiaki Takahashi, Koichi Goto, Makoto Maemondo, Yukito Ichinose, Takashi Seto, Hiroshi Sakai, Akihiko Gemma, Fumio Imamura, Masato Shingyoji, Hideo Saka, Akira Inoue, Koji Takeda, Isamu Okamoto, Katsuyuki Kiura, Satoshi Morita and Tomohide Tamura : Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC., International Journal of Clinical Oncology, Vol.24, No.5, 485-493, (発行所), (都市), March 2019. ...
閲覧 (種別) : Kazushi Yoshida, Shintaro Kanda, Hideaki Shiraishi, Keiko Goto, Kota Itahashi, Yasushi Goto, Hidehito Horinouchi, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto and Yuichiro Ohe : Difference in central nerve system metastasis during gefitinib or erlotinib therapy in patients with -mutated non-small cell lung cancer: a retrospective study., Journal of Thoracic Disease, Vol.11, No.4, 1347-1354, (発行所), (都市), April 2019. ...
閲覧 Hiroshi Nokihara : Phase III study of CBDCA/PEM followed by PEM versus DOC in elderly pts withadvanced non-sq NSCLC (JCOG1210/WJOG7813L)., 第17回日本臨床腫瘍学会学術集会, (巻), (号), (頁), July 2019. ...
閲覧 (種別) : Toyoaki Hida, Vamsidhar Velcheti, Karen L. Reckamp, Hiroshi Nokihara, Pallavi Sachdev, Tomoki Kubota, Takuya Nakada, Corina E. Dutcus, Min Ren and Tomohide Tamura : A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma., Lung Cancer, Vol.138, (号), 124-130, (発行所), (都市), Sep. 2019. ...
閲覧 (種別) : Kazuhiko Nakagawa, Toyoaki Hida, Hiroshi Nokihara, Masahiro Morise, Koichi Azuma, Young Hak Kim, Takashi Seto, Yuichi Takiguchi, Makoto Nishio, Hiroshige Yoshioka, Toru Kumagai, Katsuyuki Hotta, Satoshi Watanabe, Koichi Goto, Miyako Satouchi, Toshiyuki Kozuki, Ryo Koyama, Tetsuya Mitsudomi, Nobuyuki Yamamoto, Takashi Asakawa, Morihiko Hayashi, Wakako Hasegawa and Tomohide Tamura : Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer., Lung Cancer, Vol.139, (号), 195-199, (発行所), (都市), Nov. 2019. ...

過去3日以内に登録・変更された情報

(なし)

無効な情報 (6件)

閲覧 (種別) : Hiroaki Yanagawa, Rumi Katashima, Chiho Sato, Kenshi Takechi, Hiroshi Nokihara, Chikako Kane, Masayuki Chuma and Yuki Aoe : Research ethics consultation: an attempt and 5-year experience in a Japanese University Hospital., BMC Research Notes, Vol.11, No.1, 665, (発行所), (都市), Sep. 2018.
閲覧 (種別) : Ryosuke Oki, Yuishin Izumi, Hiroyuki Nodera, Yasutaka Sato, Hiroshi Nokihara, Kazuaki Kanai, Masahiro Sonoo, Makoto Urushitani, Kazuto Nishinaka, Naoki Atsuta, Nobuo Kohara, Toshio Shimizu, Hitoshi Kikuchi, Masaya Oda, Ken Ikeda, Makiko Nagai, Kiyonobu Komai, Yasuhiro Kojima, Daisuke Kuzume, Sagiri Isose, Shun Shimohama, Koji Abe, Hidefumi Ito, Kazuyuki Noda, Tomohiko Ishihara, Mitsuya Morita, Takayoshi Shimohata, Satoshi Teramukai, Tatsuo Kagimura, Kensuke Noma, Hiroaki Yanagawa, Satoshi Kuwabara and Ryuji Kaji : The Japanese Early-Stage Trial of High-Dose Methylcobalamin for Amyotrophic Lateral Sclerosis (JETALS): Protocol for a Randomized Controlled Trial., JMIR Research Protocols, Vol.7, No.12, e12046, (発行所), (都市), Dec. 2018.
閲覧 (種別) : Hiroshi Nokihara, Makoto Nishio, Noboru Yamamoto, Yutaka Fujiwara, Hidehito Horinouchi, Shintaro Kanda, Atsushi Horiike, Fumiyoshi Ohyanagi, Noriko Yanagitani, Linh Nguyen, Yifah Yaron, Anne Borgman and Tomohide Tamura : Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer., Clinical Lung Cancer, Vol.20, No.3, e317-e328, (発行所), (都市), Dec. 2018.
閲覧 (種別) : Masaki Hanibuchi, Akira Kanoh, Takuya Kuramoto, Tatsuro Saito, Makoto Tobiume, Atsuro Saijo, Hiroyuki Kozai, Mayo Kondo, Shun Morizumi, Hiroto Yoneda, Kozo Kagawa, Hirokazu Ogino, Seidai Sato, Hiroshi Kawano, Kenji Otsuka, Yuko Toyoda, Hiroshi Nokihara, Hisatsugu Goto and Yasuhiko Nishioka : Development, validation, and comparison of gene analysis methods for detecting mutation from non-small cell lung cancer patients-derived circulating free DNA., Oncotarget, Vol.10, No.38, 3654-3666, (発行所), (都市), June 2019.
閲覧 (種別) : Toyoaki Hida, Vamsidhar Velcheti, Karen L. Reckamp, Hiroshi Nokihara, Pallavi Sachdev, Tomoki Kubota, Takuya Nakada, Corina E. Dutcus, Min Ren and Tomohide Tamura : A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma., Lung Cancer, Vol.138, (号), 124-130, (発行所), (都市), Sep. 2019.
閲覧 (種別) : Toyoaki Hida, Vamsidhar Velcheti, Karen L. Reckamp, Hiroshi Nokihara, Pallavi Sachdev, Tomoki Kubota, Takuya Nakada, Corina E. Dutcus, Min Ren and Tomohide Tamura : A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma., Lung Cancer, Vol.138, (号), 124-130, (発行所), (都市), Sep. 2019.

本データベースでは情報の登録,保守作業の分散を主たる目的の一つとしております.したがって,上記にリストアップされている情報の保守は個々の情報の当事者に委ねられます.

ある情報を保守する義務があるかないかは,その情報に対して権限を持っているかどうかで判断してください.もちろん情報の所有者が主に管理しなくてはならないことになりますが,権限を持っている利用者が連帯してその情報の保守を行なう義務を負っていると考えてください.

貴方がどの情報について権限を持っているかは,貴方自身の情報を閲覧してください.

Number of session users = 1, LA = 0.37, Max(EID) = 375096, Max(EOID) = 1005157.